Herbas VPB

Print
EN | LT
LT - TARGETED RADIOTHERAPY CHELATES FOR IN SITU IMMUNE MODULATED CANCER VACCINATION
EN - TARGETED RADIOTHERAPY CHELATES FOR IN SITU IMMUNE MODULATED CANCER VACCINATION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/395 (2006.01)
A61K 39/39558 (2013.01)
A61K 51/06 (2006.01)
A61K2039/53 (2013.01)
A61K2039/545 (2013.01)
A61K2039/55533 (2013.01)
A61K2039/585 (2013.01)
A61K 51/0497 (2013.01)
A61K 38/2013 (2013.01)
A61K 51/0408 (2013.01)
A61P 35/00 (2018.01)
A61P 35/04 (2018.01)
A61P 37/04 (2018.01)
A61P 43/00 (2018.01)
European patent
(11) Number of the document 3487530
(13) Kind of document T
(96) European patent application number 17752519.3
Date of filing the European patent application 2017-07-25
(97) Date of publication of the European application 2019-05-29
(45) Date of publication and mention of the grant of the patent 2024-03-20
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/043645
Date 2017-07-25
PCT application publication
(87) Number WO 2018/022571
Date 2018-02-01
Priority applications
(30) Number Date Country code
201662366340 P 2016-07-25 US
Inventors
(72)
WEICHERT, Jamey , US
SONDEL, Paul, M. , US
PINCHUK, Anatoly , US
MORRIS, Zachary , US
OTTO, Mario , US
BEDNARZ, Bryan , US
CARLSON, Peter , US
Grantee
(73) Wisconsin Alumni Research Foundation , 614 Walnut Street, Madison, WI 53726, US
Title
(54) TARGETED RADIOTHERAPY CHELATES FOR IN SITU IMMUNE MODULATED CANCER VACCINATION
  TARGETED RADIOTHERAPY CHELATES FOR IN SITU IMMUNE MODULATED CANCER VACCINATION